Association between areca-stimulated vimentin expression and the progression of head and neck cancers

Head and Neck

Volumn 34, Issue 2, 2012, Pages 245-253

  Tseng, Yu Hsin ^a   Chang, Kuo Wei ^a,b   Yang, Cheng Chieh ^a,b   Liu, Chung Ji ^a,c   Kao, Shou Yen ^a,b   Liu, Tsung Yun ^b   Lin, Shu Chun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

areca nut chewing; head and neck cancer; invasion; vimentin

Indexed keywords

ARECA NUT EXTRACT; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ARECA; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CANCER TISSUE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MASTICATION; NUT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ARECA; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CYCLOOXYGENASE 2; DISEASE PROGRESSION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHENOTYPE; PLANT EXTRACTS; TUMOR CELLS, CULTURED; UP-REGULATION; VIMENTIN;

EID: 84862972694     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21726     Document Type: Article

References (22)

1. Shieh TM, Lin SC, Liu CJ, Chang SS, Ku TH, Chang KW,. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res 2007; 13 (15 Pt 1): 4378-4385.
2. Chen YJ, Liao CT, Chen PJ, et al. Downregulation of Ches1 and other novel genes in oral cancer cells chronically exposed to areca nut extract. Head Neck 2010 [Epub ahead of print].
3. Trivedy CR, Craig G, Warnakulasuriya S,. The oral health consequences of chewing areca nut. Addict Biol 2002; 7: 115-125. (Pubitemid 34087915)
4. Lin SC, Lu SY, Lee SY, Lin CY, Chen CH, Chang KW,. Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int J Cancer 2005; 116: 526-535.
5. Lu HH, Liu CJ, Liu TY, Kao SY, Lin SC, Chang KW,. Areca-treated fibroblasts enhance tumorigenesis of oral epithelial cells. J Dent Res 2008; 87: 1069-1074.
6. Lu SY, Chang KW, Liu CJ, et al. Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis 2006; 27: 1273-1284.
7. Tseng YH, Chang CS, Liu TY, Kao SY, Chang KW, Lin SC,. Areca nut extract treatment down-regulates involucrin in normal human oral keratinocyte through P13K/AKT activation. Oral Oncol 2007; 43: 670-679.
8. Tseng YH, Chang KW, Liu CJ, Lin CY, Yang SC, Lin SC,. Areca nut extract represses migration and differentiation while activating matrix metalloproteinase-9 of normal gingival epithelial cells. J Periodontal Res 2008; 43: 490-499.
9. Chang MC, Wu HL, Lee JJ, et al. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem 2004; 279: 50676-50683.
10. Lee JM, Dedhar S, Kalluri R, Thompson EW,. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981.
11. Takkunen M, Grenman R, Hukkanen M, Korhonen M, García de Herreros A, Virtanen I,. Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem 2006; 54: 1263-1275. (Pubitemid 44623347)
12. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H,. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007; 26: 711-724. (Pubitemid 46204250)
13. Frederick BA, Helfrich BA, Coldren CD, et al. Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma. Mol Cancer Ther 2007; 6: 1683-1691. (Pubitemid 46954044)
14. Orlichenko LS, Radisky DC,. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 2008; 25: 593-600.
15. Yang MH, Wu MZ, Chiou SH, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295-305.
16. Tu HF, Chen HW, Kao SY, Lin SC, Liu CJ, Chang KW,. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol 2008; 87: 243-252.
17. Kurihara Y, Hatori M, Ando Y, et al. Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation. Clin Exp Metastasis 2009; 26: 425-432.
18. Eckes B, Dogic D, Colucci-Guyon E, et al. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci 1998; 111 (Pt 13): 1897-1907. (Pubitemid 28370534)
19. Zhao Y, Yan Q, Long X, Chen X, Wang Y,. Vimentin affects the mobility and invasiveness of prostate cancer cells. Cell Biochem Funct 2008; 26: 571-577.
20. Rodriguez-Pinilla SM, Sarriõ D, Honrado E, et al. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J Clin Pathol 2007; 60: 1006-1012. (Pubitemid 47441933)
21. McInroy L, Määttä A,. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 2007; 360: 109-114. (Pubitemid 46990330)
22. Jungert K, Buck A, von Wichert G, et al. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res 2007; 67: 1563-1570. (Pubitemid 46383380)